Improving CRISPR-Cas technology for therapeutic applications
- Authors: Logvina N.A.1, Kopnin I.P.1, Aparin I.O.1, Zatsepin T.S.1,2
-
Affiliations:
- Center of Life Sciences, Skolkovo Institute of Science and Technology
- Chemistry Department, Lomonosov Moscow State University
- Issue: Vol 14, No 3 (2019): Supplement
- Pages: 13-14
- Section: Articles
- Submitted: 16.01.2023
- Published: 15.12.2019
- URL: https://genescells.ru/2313-1829/article/view/122052
- DOI: https://doi.org/10.23868/gc122052
- ID: 122052
Cite item
Abstract
Full Text
About the authors
Nataliya A. Logvina
Center of Life Sciences, Skolkovo Institute of Science and Technology
Email: n.logvina@skoltech.ru
Ilya P. Kopnin
Center of Life Sciences, Skolkovo Institute of Science and Technology
Ilya O. Aparin
Center of Life Sciences, Skolkovo Institute of Science and Technology
Timofei S. Zatsepin
Center of Life Sciences, Skolkovo Institute of Science and Technology; Chemistry Department, Lomonosov Moscow State University